The CRM197 protein or MenX-CRM, MenA-CRM197, and GBSII-CRM197 glycoconjugates in the amount of 2–10 μg were separated by 8% SDS-PAGE. Fab fragments in the amount of 2–10 μg were separated by 10–12% SDS-PAGE. Samples were transferred onto a 0.45 μm PVDF membrane (Hybond™, GE Healthcare), which were subsequently blocked with 5% w/v blotting grade low-fat powdered milk (Carl Roth Gmbh & Co. Kg). Membranes were incubated with clone MenX.01 (mAb or Fab) overnight at 4 °C. We used our own stock antibodies at a concentration of 1 mg/ml with a typical dilution of the primary antibody being 1:100. Protein signals were developed using anti-mouse IgG F (ab’) 2 peroxidase (Jackson ImmunoResearch) 1:1,000 and visualized with an ImageQuant LAS 4000 mini camera system (GE Healthcare). Fab fragments were developed with either anti-mouse IgG F (ab’)2 peroxidase (Jackson ImmunoResearch) diluted 1:1,000 or anti-mouse IgG (H + L) Fc peroxidase (Jackson ImmunoResearch) diluted 1:1,000 to confirm the absence of the Fc fragment in the preparation.
+ Open protocol